Abstract
Diffuse large cell lymphoma involving bone marrow is not uncommon, but primary, de novo, bone marrow diffuse large B cell lymphoma (DLBCL) is rare. To understand the clinical features and outcomes of this distinct entity, we collected 12 cases in 5 years from a single-center database. They accounted for 1.16% of lymphoma, or 2.65% of diffuse large B cell lymphoma. Nine cases presented with fever of unknown origin. Lactate dehydrogenase levels were elevated in all but one case. Nine cases belonged to the high-risk group according to their international prognosis indexes (score 4 or 5). Four patients received no chemotherapy, all of whom died within 1 month. Four patients received cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP)-like chemotherapy, and their median survival was 13 months. Finally, four patients received rituximab 375 mg/m2 in addition to CHOP-like chemotherapy. All of them had complete remission and three are still alive without relapse. We concluded that primary bone marrow DLBCL is a rare but distinctive subtype of lymphoma. The prognosis for this entity is poor but rituximab-based treatment is promising for improving its outcomes.
Similar content being viewed by others
References
Strauchen JA (2003) Primary bone marrow B-cell lymphoma: report of four cases. Mt Sinai J Med 70(2):133–138
Kajiura D, Yamashita Y, Mori N (2007) Diffuse large B-cell lymphoma initially manifesting in the bone marrow. Am J Clin Pathol 127(5):762–769
Alvares CL, Matutes E, Scully MA, Swansbury J, Min T, Gruszka-Westwood AM, Atkinson S, Hilditch B, Morilla R, Wotherspoon AC, Catovsky D (2004) Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings. Leuk Lymphoma 45(4):769–775
Hishizawa M, Okamoto K, Chonabayashi K, Kaneko H, Watanabe M, Tsudo M (2007) Primary large B-cell lymphoma of the bone marrow. Br J Haematol 136(3):351
Wong KF, Chan JK, Ng CS, Chu YC, Li LP, Chan CH (1992) Large cell lymphoma with initial presentation in the bone marrow. Hematol Oncol 10(5):261–271
Staples WG, Getaz EP (1977) Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy. S Afr Med J 52(2):60–63
Bain B, Matutes E, Robinson D, Lampert IA, Brito-Babapulle V, Morilla R, Catovsky D (1991) Leukaemia as a manifestation of large cell lymphoma. Br J Haematol 77(3):301–310
Kong SY, Cho EH, Woo HY, Park Q, Ko YH, Kim SH (2004) De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean. J Korean Med Sci 19(6):815–819
Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, Suzumiya J, Murase T, Miura I, Akasaka T, Tamaru J, Suzuki R, Kagami Y, Hirano M, Morishima Y, Ueda R, Shiku H, Nakamura S (2002) De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99(3):815–821
Yoshida K, Kayano H, Akiba M, Kishimoto K, Takahashi N, Sugahara Y, Kawai N, Matsuda A, Hirashima K, Suzuki T, Bessho M (2002) De novo CD5-positive diffuse large B-cell lymphoma with leukemic dissemination diagnosed by immunohistochemical examinations of bone marrow clot sections. Rinsho Ketsueki 43(10):943–948
Anonymous (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. N Engl J Med 329(14):987–994
Aung W, Koslosky W, Chin NW, Pincus MR (1996) Diffuse large cell lymphoma of B-cell type associated with reactive hemophagocytosis. Ann Clin Lab Sci 26(5):433–436
Shimazaki C, Inaba T, Okano A, Hatsuse M, Takahashi R, Hirai H, Sudo Y, Ashihara E, Adachi Y, Murakami S, Saigo K, Tsuda H, Fujita N, Nakagawa M (2001) Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHS. Intern Med 40(9):878–882
Shimazaki C, Inaba T, Nakagawa M (2000) B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma 38(1–2):121–130
Chen WL, Tsai WC, Chao TY, Sheu LF, Chou JM, Kao WY, Chen YC, Ho CL (2009) The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol 89:553–562
Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, Kojima M, Miura I, Mori N, Yoshino T, Nakamura S (2007) Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood 109(2):478–485
Murase T, Nakamura S, Kawauchi K, Matsuzaki H, Sakai C, Inaba T, Nasu K, Tashiro K, Suchi T, Saito H (2000) An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol 111(3):826–834
Nakamura N, Hashimoto Y, Kuze T, Tasaki K, Sasaki Y, Sato M, Abe M (1999) Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma. Lab Invest 79(8):925–933
Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H (1998) De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91(4):1145–1151
Harada S, Suzuki R, Uehira K, Yatabe Y, Kagami Y, Ogura M, Suzuki H, Oyama A, Kodera Y, Ueda R, Morishima Y, Nakamura S, Seto M (1999) Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5− with CD10+ groups may constitute clinically relevant subtypes. Leukemia 13(9):1441–1447
Matolcsy A, Nador RG, Cesarman E, Knowles DM (1998) Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol 153(5):1609–1614
Financial supports
This work is supported by the grant DOH99-TD-C-111-006 from the Department of Health, Executive Yuan, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chang, H., Hung, YS., Lin, TL. et al. Primary bone marrow diffuse large B cell lymphoma: a case series and review. Ann Hematol 90, 791–796 (2011). https://doi.org/10.1007/s00277-010-1129-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-010-1129-4